SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Anthony Wong who wrote (5166)8/25/1998 6:58:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Viagra Firm Set For New Fortune With 'Anti-Obesity' Drug
Tuesday August 25, 6:59 AM

The maker of impotency drug Viagra could be set to make another fortune with a new medicine being developed in Cambridge to combat obesity.

American drugs group Pfizer has signed a œ24 million licensing and development deal with Cambridge research outfit Phytopharm to develop an appetite-suppressing chemical derived from a South African plant.

Preliminary trials suggest the new drug will not have the potential nasty side-effects produced by previous amphetamine-based formulas.

yahoo.co.uk